Bancreek Capital Management LP Buys 125,844 Shares of Avantor, Inc. (NYSE:AVTR)

Bancreek Capital Management LP grew its stake in Avantor, Inc. (NYSE:AVTR) by 21.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 721,088 shares of the company’s stock after purchasing an additional 125,844 shares during the quarter. Avantor comprises approximately 11.8% of Bancreek Capital Management LP’s holdings, making the stock its largest holding. Bancreek Capital Management LP owned 0.11% of Avantor worth $18,655,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Intech Investment Management LLC lifted its position in Avantor by 1.8% during the second quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock worth $616,000 after acquiring an additional 514 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Avantor by 0.3% in the second quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after purchasing an additional 528 shares during the last quarter. Veracity Capital LLC grew its stake in shares of Avantor by 1.0% in the third quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after purchasing an additional 543 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Avantor by 2.8% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock worth $571,000 after purchasing an additional 733 shares during the last quarter. Finally, US Bancorp DE lifted its holdings in Avantor by 6.2% in the third quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after buying an additional 734 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the topic of several research reports. TD Cowen upped their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Stifel Nicolaus upped their price objective on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. UBS Group lowered their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Finally, Barclays lowered their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Price Performance

Shares of NYSE AVTR opened at $21.80 on Wednesday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The stock has a fifty day moving average price of $24.84 and a 200 day moving average price of $24.08. Avantor, Inc. has a 1-year low of $18.41 and a 1-year high of $28.00. The company has a market cap of $14.84 billion, a PE ratio of 47.39, a P/E/G ratio of 2.70 and a beta of 1.35.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.